Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Transl Res. 2016 Nov 1;182:1–13. doi: 10.1016/j.trsl.2016.10.010

Table 4.

Differentially Expressed Transcripts at Flare and After Treatment in Non-Responders

Transcripts Differentially-Expressed
Compared to Normal Kidney at Biopsy 1
Change in Transcript Expression
from Biopsy 1 to Biopsy 2
Transcripts that Become Differentially-Expressed
Compared to Normal After Treatment at Biopsy 2
Gene Fold Change1 P2 Percent Change3 P4 Gene Fold Change1 P2
C1QB 4.52 0.0000 −38% 0.04 CFD 8.01 0.0002
MX1 3.90 0.004 67% 0.29 CCL19 5.94 0.0006
ITGAL 3.73 0.0001 66% 0.09 C3 4.96 0.001
ITGB2 3.48 0.0000 25% 0.39 SELL 4.22 0.003
CYBB 3.41 0.0000 59% 0.07 CX3CR1 3.74 0.0000
FCER1G 3.41 0.0004 33% 0.27 CASP1 3.24 0.0000
FCGR3A 3.35 0.006 35% 0.48 IFITM1 3.09 0.006
STAT1 3.09 0.0008 39% 0.25 ITGAX 3.08 0.0007
C1S 3.00 0.0000 10% 0.60 B2M 2.87 0.009
BST2 2.88 0.0000 8% 0.75 CD40 2.87 0.009
C1R 2.79 0.001 −5% 0.85 LCK 2.82 0.0005
FN1 2.75 0.001 −25% 0.36 LCP2 2.77 0.0001
LAIR1 2.68 0.0000 −5% 0.78 C2 2.77 0.008
TGFBI 2.62 0.002 17% 0.59 SLAMF7 2.76 0.008
KIR2DL3 2.51 0.009 −50% 0.04 IL1RN 2.73 0.001
GZMA 2.48 0.002 24% 0.34 IRF8 2.72 0.005
HLA-B 2.44 0.0001 29% 0.27 TAGAP 2.66 0.009
HLA-DRB3 2.44 0.002 37% 0.28 IFI16 2.66 0.0000
LILRA3 2.39 0.001 21% 0.46 JAK3 2.61 0.01
IRF7 2.23 0.009 34% 0.36 FCGR2B 2.61 0.003
HLA-A 2.23 0.004 3% 0.90 CD5 2.55 0.009
BTK 2.20 −1% 0.10 PTPN6 2.42
0.001 0.0001
PTPRC 2.20 0.01 115% 0.01 ZAP70 2.34 0.006
CSF2RB 2.19 0.002 85% 0.01 NCF4 2.34 0.0009
TNF 2.18 0.0009 48% 0.15 TGFB1 2.34 0.0002
CD6 2.05 0.005 −10% 0.64 ITGAM 2.27 0.0007
MR1 0.50 0.001 10% 0.68 GZMB 2.26 0.003
NOS2 0.49 0.008 45% 0.10 ARHGDIB 2.26 0.0000
CEBPB 0.48 0.002 13% 0.58 CD24 2.25 0.002
ITGA6 0.46 0.0006 −13% 0.51 TLR1 2.21 0.0000
IGF2R 0.45 0.006 −9% 0.74 IKZF1 2.19 0.008
IL6R 0.44 0.0001 4% 0.88 LILRB1 2.18 0.007
C9 0.43 0.0007 −8% 0.71 PRF1 2.15 0.003
ICOSLG 0.43 0.0001 −35% 0.03 CXCL13 2.11 0.008
TFRC 0.42 0.0002 −23% 0.21 CD97 2.11 0.001
CR1 0.42 0.002 33% 0.32 STAT2 2.07 0.0000
BST1 0.41 0.001 32% 0.29 NFATC1 0.50 0.004
SELE 0.40 0.0008 15% 0.61 LTB4R2 0.50 0.003
CISH 0.38 0.0000 −6% 0.73 MAPKAPK2 0.49 0.001
CDKN1 A 0.30 0.0000 −3% 0.90 GPI 0.49 0.001
RORC 0.22 0.0000 −6% 0.81 IL8 0.47 0.004
DPP4 0.22 0.003 −17% 0.67 PDGFB 0.46 0.003
NFIL3 0.21 0.0000 4% 0.90 TRAF4 0.46 0.002
MME 0.15 0.0000 −5% 0.88 CTNNB1 0.45 0.0002
CR2 0.12 0.0000 76% 0.17 CRADD 0.45 0.0006
TAL1 0.45 0.001
CD8B 0.44 0.003
NFKBIA 0.44 0.0000
TOLLIP 0.40 0.001
CTSC 0.40 0.0002
CD274 0.40 0.009
C5 0.38 0.0000
KIT 0.37 0.002
IL12RB1 0.35 0.008
BLNK 0.35 0.0003
C6 0.35 0.0000
CD81 0.34 0.008
C1QBP 0.34 0.003
CEACAM6 0.33 0.005
CFI 0.29 0.0001
CX3CL1 0.28 0.0001
VTN 0.25 0.0001
ABCB1 0.25 0.0005
DEFB1 0.23 0.002
SPP1 0.17 0.001
FKBP5 0.14 0.0004
1

Transcript expression in LN compared to normal controls

2

LN versus normal; p≤0.01 and fold change compared to normal >2 or <0.5 to be considered differentially expressed

3

Transcript expression from biopsy 1 to biopsy 2

4

Biopsy 1 versus biopsy 2